Chen et al. (2018b) demonstrated how activation of TrkB signaling in AD-like disease in a rat model by deoxygedunin reduces D-galactose-induced Aβ buildup in the hippocampus and related oxidative stress and cognitive impairment. The gene discussed is NTRK2; the disease is Cognitive impairment.